(Q41822803)

12 October 2017

The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise (English)

1 reference

12 October 2017

1 reference

S Sundberg

1

1 reference

12 October 2017

M Scheinin

2

1 reference

12 October 2017

A Illi

3

1 reference

12 October 2017

J Akkila

4

1 reference

12 October 2017

A Gordin

5

1 reference

12 October 2017

T Keränen

6

1 reference

12 October 2017

language of work or name

English

0 references

publication date

1 November 1993

1 reference

British Journal of Clinical Pharmacology

12 October 2017

1 reference

12 October 2017

36

1 reference

12 October 2017

5

1 reference

12 October 2017

451-456

1 reference

Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines

12 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Purification and kinetic mechanism of human brain soluble catechol-O-methyltransferase.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Hypokalaemia and other non-bronchial effects of inhaled fenoterol and salbutamol: a placebo-controlled dose-response study in healthy volunteers

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease.

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Expression of heat shock proteins in Alzheimer's disease

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

CGP 28014, a new inhibitor of cerebral catechol-O-methylation with a non-catechol structure

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Plasma 3,4-dihydroxyphenylglycol (DHPG) and 3-methoxy-4-hydroxyphenylglycol (MHPG) are insensitive indicators of alpha 2-adrenoceptor mediated regulation of norepinephrine release in healthy human volunteers

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Catechol-O-methyl transferase: pharmacological aspects and physiological role

6 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1364618

Inhibition of human erythrocyte and gastroduodenal catechol-O-methyltransferase activity by nitecapone

6 June 2018

1 reference

12 December 2020

Liquid chromatographic determination of a new catechol-O-methyltransferase inhibitor, entacapone, and its Z-isomer in human plasma and urine

1 reference

12 December 2020

1 reference

12 December 2020

The effect of catechol-O-methyl transferase inhibition by entacapone on the pharmacokinetics and metabolism of levodopa in healthy volunteers

1 reference

12 December 2020

Kinetic Properties of a Soluble Catechol O-Methyltransferase of Human Liver

1 reference

12 December 2020

Human erythrocyte catechol-o-methyltransferase: Correlation with lung and kidney activity

1 reference

12 December 2020

Measurement of 3-methoxy-4-hydroxyphenylglycol in human plasma with high-performance liquid chromatography using electrochemical detection

1 reference

12 December 2020

Catechol-O-methyltransferase activity in human and rat small intestine

1 reference

12 December 2020

Favorable effect of catechol-O-methyltransferase inhibition by OR-462 in experimental models of Parkinson's disease

1 reference

12 December 2020

Effect of a novel catechol-O-methyltransferase inhibitor, nitecapone, on the metabolism of L-dopa in healthy volunteers

1 reference

12 December 2020

10.1111/J.1365-2125.1993.TB00394.X

Identifiers

DOI

1 reference

12 October 2017

1 reference

12 October 2017

PubMed publication ID

12959293

1 reference